급성기 뇌경색 환자에서 뇌 자기공명영상의 확산-관류 불일치가 임상적 예후를 예측할 수 있는가?-rCBV를 중심으로-
Can Diffusion-Perfusion Mismatch on Brain MRI in Acute Ischemic Stroke Patients Predict Clinical Outcome?-Preliminary Study Focused on rCBV-
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: Diffusion-perfusion mismatch (DPM) on MRI has been considered an ischemic penumbra. However, several reports have demonstrated limitation of DPM on MRI as a predictable marker of the ischemic penumbra. In this study, we investigated the relationship between DPM and the clinical progression in acute ischemic stroke patients. Methods: We consecutively recruited fifty-seven patients showing acute ischemic stroke (within 24 hours) in the middle cerebral artery (MCA) territory. The clinical outcomes were determined by serial measurement of National Institute of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) during 30 days after their ischemic event. We also evaluated the relationship among the parameters of perfusion MRI and the clinical worsening in patients with DPM on initial MRI. Results: Nineteen (33.3%) patients had DPM on MRI within 24 hours after stroke onset. Even though the frequency of clinical worsening for 30 days after stroke onset was higher in DPM group (26%) than in non-DPM group (11%), it did not reach statistical significance (p=0.143). However, extent of MCA stenosis (p<0.001) and time to peak (TTP) delay on MRI (p<0.001) were significantly greater in patients with DPM than in those without DPM. Among several parameters of the perfusion MRI, only relative cerebral blood volume (rCBV) was significantly related to the clinical worsening (62.9±24.7% vs 96.1±19.2%, p=0.007) in patients with DPM. Conclusions: This study shows that DPM on MRI does not always predict the clinical worsening in acute ischemic stroke. To overcome this problem, we should analyze rCBV map based DPM as well as TTP map based DPM.
Abstract
Background: Diffusion-perfusion mismatch (DPM) on MRI has been considered an ischemic penumbra. However, several reports have demonstrated limitation of DPM on MRI as a predictable marker of the ischemic penumbra. In this study, we investigated the relationship between DPM and the clinical progression in acute ischemic stroke patients. Methods: We consecutively recruited fifty-seven patients showing acute ischemic stroke (within 24 hours) in the middle cerebral artery (MCA) territory. The clinical outcomes were determined by serial measurement of National Institute of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) during 30 days after their ischemic event. We also evaluated the relationship among the parameters of perfusion MRI and the clinical worsening in patients with DPM on initial MRI. Results: Nineteen (33.3%) patients had DPM on MRI within 24 hours after stroke onset. Even though the frequency of clinical worsening for 30 days after stroke onset was higher in DPM group (26%) than in non-DPM group (11%), it did not reach statistical significance (p=0.143). However, extent of MCA stenosis (p<0.001) and time to peak (TTP) delay on MRI (p<0.001) were significantly greater in patients with DPM than in those without DPM. Among several parameters of the perfusion MRI, only relative cerebral blood volume (rCBV) was significantly related to the clinical worsening (62.9±24.7% vs 96.1±19.2%, p=0.007) in patients with DPM. Conclusions: This study shows that DPM on MRI does not always predict the clinical worsening in acute ischemic stroke. To overcome this problem, we should analyze rCBV map based DPM as well as TTP map based DPM.
참고문헌 (24)
- The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, "Tissue plasminogen activator for acute ischemic stroke", N Engl J Med, 333, pp.1581~1587 (1995)
- Adams H, "Stroke Council of the American Heart Association", American Stroke Association, 2005, pp.36, 916~923[DOI]
- Hakim AM, "The cerebral ischemic penumbra", Can J Neurol Sci, 14, pp.557~559 (1987)
- Baron JC, "Mapping the ischaemic penumbra with PET: implications for acute stroke treatment", Cerebrovasc Dis, 9, pp.193~201 (1999)
- Hossmann KA, "Viability thresholds and the penumbra of focal ischemia", Ann Neurol, 36, pp.557~565 (1994)
- Ginsberg MD, "The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke", Ann Neurol, 36, pp.553~554 (1994)
- Clark WM, "Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomised controlled trial", JAMA, 282, pp.2019~2026 (1999)
- Hacke W, "Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)", JAMA, 274, pp.1017~1025 (1995)
- Hacke W, "Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators", Lancet, 352, pp.1245~1251 (1998)
- Hacke W, "NINDS rt-PA Study Group Investigators. Associationof outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials", Lancet, 363, pp.768~774 (2004)
- Kane I, "Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date", J Neurol Neurosurg Psychiatry, 78, pp.485~491 (2007)
- Yamada K, "Magnetic resonance perfusion-weighted imaging of acute cerebral infarction; effect of the calculation methods and underlying vasculopathy", Stroke, 33, pp.87~94 (2002)
- Neumann-Haefelin T, "Diffusion- and perfusion-weighted MRI. The DWI", PWI mismatch region in acute stroke, 1999, pp.30, 1591~1597
- Sobesky J, "Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke", Stroke, 36, pp.980~985 (2005)
- Rordorf G, "Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI", Stroke, 29, pp.939~943 (1998)
- Sorensen AG, "Hyperacute stroke: evaluation with combined multisection diffusionweighted and hemodynamically weighted echo-planar MR imaging", Radiology, 199, pp.391~401 (1996)
- Adams HP Jr, "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment", Stroke, 24, pp.35~41 (1993)
- Heiss WD, "Experimental evidence of ischemic thresholds and functional recovery", Stroke, 23, pp.1668~1672 (1992)
- Wise RJ, "Disturbance of oxidative metabolism of glucose in recent human cerebral infarcts", Ann Neurol, 14, pp.627~637 (1983)
- Marchal G, "Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET–CT study with voxel-based data analysis", Stroke, 27, pp.599~606 (1996)
- Fiehler J, "Severe ADC decreases do not predict irreversible tissue damage in humans", Stroke, 33, pp.79~86 (2002)
- Fiehler J, "Predictors of apparent diffusion coefficient normalization in stroke patients", Stroke, 35, pp.514~519 (2004)
- Neumann-Haefelin T, "Diffusion- and perfusion-weighted MRI: influence of severe carotid artery stenosis on the DWI", PWI mismatch in acute stroke, 2000, pp.31, 1311~1317
- Richard E, "The roles of diffusion and perfusion MR imaging in acute stroke management", Am J Neuroradiol, 20, pp.957~959 (1999)